NanoGuardian / Pharmaceutical Brand Protection

Pharmaceutical Brand Protection

Consumers place an incredible amount of trust in the pharmaceutical industry, with reliance that the medications they are taking are the exact medications prescribed by their physicians. Unfortunately, the threat and reality of counterfeit medicine continues to rise with each passing day. With an estimated $40 billion in counterfeit pharmaceuticals and an additional $15 billion in diverted products entering the pharmaceutical supply chain each year, the consequences for many patients and their families are devastating. Even in cases where there is no apparent harm, the entire supply chain is affected. The physician and pharmacist lose credibility, wholesaler business activities are questioned, and the manufacturer can appear negligent and lose billions in revenue.

Traditionally, pharmaceutical manufacturers have focused on securing product through on-package technologies, but motivated counterfeiters have been able to copy virtually every overt technology available. As such, package protection alone does not offer the security needed when criminals can make nearly perfect copies of both the drug and the package.

NanoGuardian™, a division of NanoInk, is establishing its role as an anti-counterfeiting pioneer in the pharmaceutical industry with the introduction of its NanoEncryption™ technology, which provides the only true forensic, multi-layered, track and trace brand protection at the individual dosage level. NanoEncryption technology can be applied directly to tablets, capsules, and vials with NanoCodes™ containing an unlimited amount of data determined by manufacturers including batch and manufacturing information, expiration date, and the targeted site of distribution including country, state and specific wholesaler if desired. This data can also be linked to package technologies like radio frequency identification (RFID) and 2-D Barcodes for a true multi-layered protective shield of the medication from plant to patient. In addition, NanoEncryption technology can only be detected with highly specialized authentication tools located at NanoGuardian Authentication Centers furthering the integrity of NanoGuardian's Brand Protection process.

The practice of counterfeiting and illegal diversion affects products beyond pharmaceuticals, including the authenticity of currency, auto and aircraft parts, medical devices, ID cards, consumer and luxury goods, software, tobacco, electronic parts and more. NanoGuardian has targeted pharmaceuticals first, but is now extending its NanoEncryption technology to other highly counterfeited industries.

Counterfeit and untagged drugs easily enter the supply chain in untraceable packaging.

Source: GAO Report, June 2004